These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35090380)

  • 1. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.
    Meynier M; Baudu E; Rolhion N; Defaye M; Straube M; Daugey V; Modoux M; Wawrzyniak I; Delbac F; Villéger R; Méleine M; Borras Nogues E; Godfraind C; Barnich N; Ardid D; Poirier P; Sokol H; Chatel JM; Langella P; Livrelli V; Bonnet M; Carvalho FA
    Gut Microbes; 2022; 14(1):2022997. PubMed ID: 35090380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pasteurized
    Meynier M; Daugey V; Mallaret G; Gervason S; Meleine M; Barbier J; Aissouni Y; Lolignier S; Bonnet M; Ardid D; De Vos WM; Van Hul M; Suenaert P; Brochot A; Cani PD; Carvalho FA
    Gut Microbes; 2024; 16(1):2298026. PubMed ID: 38170633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome.
    Bao CH; Wang CY; Li GN; Yan YL; Wang D; Jin XM; Wu LY; Liu HR; Wang XM; Shi Z; Wu HG
    World J Gastroenterol; 2019 Aug; 25(32):4696-4714. PubMed ID: 31528095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinisan Alleviates Stress-Induced Intestinal Dysfunction and Depressive-like Behaviors in Mice with Irritable Bowel Syndrome by Enhancing the Intestinal Barrier and Modulating Central 5-Hydroxytryptamine.
    Zeng H; Jiang Y; Yin Q; Li X; Xiong Y; Li B; Xu X; Hu H; Qian G
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
    J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome.
    Constante M; De Palma G; Lu J; Jury J; Rondeau L; Caminero A; Collins SM; Verdu EF; Bercik P
    Neurogastroenterol Motil; 2021 Mar; 33(3):e13985. PubMed ID: 32955166
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Xia B; Lin T; Li Z; Wang J; Sun Y; Wang D; Ye J; Zhang Y; Kou R; Zhao B; Yi J; Bai G; Liu X
    J Agric Food Chem; 2024 Aug; 72(32):17989-18002. PubMed ID: 39082086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
    Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review.
    Lupu VV; Ghiciuc CM; Stefanescu G; Mihai CM; Popp A; Sasaran MO; Bozomitu L; Starcea IM; Adam Raileanu A; Lupu A
    World J Gastroenterol; 2023 Jun; 29(21):3241-3256. PubMed ID: 37377581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
    Fredericks E; Theunissen R; Roux S
    Turk J Gastroenterol; 2020 Dec; 31(12):840-847. PubMed ID: 33625995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity.
    Yang W; Yu T; Huang X; Bilotta AJ; Xu L; Lu Y; Sun J; Pan F; Zhou J; Zhang W; Yao S; Maynard CL; Singh N; Dann SM; Liu Z; Cong Y
    Nat Commun; 2020 Sep; 11(1):4457. PubMed ID: 32901017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
    BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome.
    Ivashkin V; Poluektov Y; Kogan E; Shifrin O; Sheptulin A; Kovaleva A; Kurbatova A; Krasnov G; Poluektova E
    PLoS One; 2021; 16(6):e0252930. PubMed ID: 34115808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
    Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N
    World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice.
    Wang X; Huang S; Zhang M; Su Y; Pan Z; Liang J; Xie X; Wang Q; Chen J; Zhou L; Luo X
    J Ethnopharmacol; 2023 Feb; 302(Pt B):115919. PubMed ID: 36356716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence from comparative genomic analyses indicating that
    Liu Y; Xiao W; Yu L; Tian F; Wang G; Lu W; Narbad A; Chen W; Zhai Q
    Food Funct; 2021 Feb; 12(3):1121-1134. PubMed ID: 33427835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.